Nasus Pharma Ltd.
NSRX | AMEX
$3.16
-$0.15 (-4.53%)
At close: Oct 30, 2026, 3:59 PM ET
$3.16
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 3:59 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -1.4M | -1.4M | -1.4M | -1.58K | -1.91K | -1.72K | -1.53K | -1.62K | -1.71K | -1.38K | -1.05K | -632.50 | -214 | -107 |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 513 | 331.50 | 150 | 150 | 150 | 75 | n/a | 7 | 14 | 26.50 | 39 | 32 | 25 | 12.50 |
Other Working Capital | -270.15K | -171.46K | -171.29K | 74.16K | 74.21K | 383.50 | 410 | 445.50 | 481 | 382 | 283 | 202 | 121 | 60.50 |
Other Non-Cash Items | -1.57M | 32.94K | 33.41K | -197.24K | -197.2K | 465 | 447 | 461.50 | 476 | 88 | -300 | -354.50 | -409 | -204.50 |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -386.93K | -125.51K | -125.34K | 77.78K | 77.82K | 383.50 | 410 | 445.50 | 481 | 382 | 283 | 202 | 121 | 60.50 |
Operating Cash Flow | -3.36M | -1.49M | -1.49M | -120.89K | -121.13K | -791.50 | -665 | -698.50 | -732 | -880.50 | -1.03K | -753 | -477 | -238.50 |
Capital Expenditures | -5.55K | -4.23K | -4.23K | 3 | 3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -907.01K | -907.01K | -907.01K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -315.09K | -477.50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -1.23M | -911.72K | -911.24K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | 31.39K | 131.52K | 131.52K | 100.13K | 100.13K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 6.8K | 6.8K | 180 | 124.50 | 69 | 509.50 | 770 | 825.50 | 881 | 968 | 1.06K | 1.06K | 1.06K | 527.50 |
Financial Cash Flow | 7.08M | 2.7M | 2.7M | 100.25K | 100.2K | 509.50 | 770 | 825.50 | 881 | 968 | 1.06K | 1.06K | 1.06K | 527.50 |
Net Cash Flow | 2.58M | 404.84K | 404.84K | 68.66K | 67.98K | n/a | n/a | n/a | 165 | n/a | n/a | n/a | 751 | n/a |
Free Cash Flow | -3.36M | -1.49M | -1.49M | -120.89K | -121.13K | -791.50 | -665 | -698.50 | -732 | -880.50 | -1.03K | -753 | -477 | -238.50 |
Adj. Free Cash Flow | -3.36M | -1.49M | -1.49M | -121.04K | -121.28K | -866.50 | -665 | -705.50 | -746 | -907 | -1.07K | -785 | -502 | -251 |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | -5.55K | -4.23K | -4.23K | 3 | 3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -3.36M | -1.49M | -1.49M | -120.89K | -121.13K | -791.50 | -665 | -698.50 | -732 | -880.50 | -1.03K | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove NSRX